Polsky Bruce 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Polsky Bruce
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-17+61,264→ 61,264 totalExercise: $6.50Exp: 2032-06-16→ Common Stock (61,264 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.